Research

  • AI designs nanoparticles to enhance drug delivery

    Biomedical engineers at Duke University have developed a platform that combines automated lab methods with artificial intelligence to design nanoparticles for drug delivery. The system helps researchers identify and optimise recipes for nanoparticles – tiny carriers that encapsulate drugs and deliver them to specific sites in the body. In a proof of concept, it created [...]

  • Investors and innovators urge action on UK MedTech bottlenecks

    The Centre for Process Innovation (CPI) today published three interconnected reports offering the most comprehensive analysis to date of the challenges facing UK MedTech innovators. Drawing on insights from 240 small and medium-sized enterprises (SMEs), 100 investors and 10 university technology transfer offices, the reports spell out the solutions needed to unlock the full potential [...]

  • Millions to benefits as NHS trials AI screening system

    Millions of patients could get faster diagnoses as artificial intelligence (AI) tools are trialled across NHS screening services through a new cloud-based research platform. The AI Research Screening Platform (AIR-SP), backed by nearly £6m in government funding, is being developed by NHS England. It will allow trusts across the country to join trials of AI [...]

  • AI model could advance autism diagnosis

    A deep learning model achieved up to 98 per cent accuracy in distinguishing autistic from neurotypical participants. The artificial intelligence system analyses resting-state fMRI scans – brain imaging that tracks blood-oxygen changes – and produces maps showing which brain regions shaped its decisions. Researchers from the University of Plymouth tested the model on data from [...]

  • Experts back ketamine for depression but urge caution on psychedelics ‘hype’

    The Royal College of Psychiatrists says large trials suggest ketamine-based drugs may ease depression symptoms. Experts have backed the use of ketamine in depression treatment, while stressing that more evidence is needed before other psychedelics can be considered safe. The Royal College of Psychiatrists (RCPsych) issued a position statement highlighting ketamine, saying it is "the [...]

  • CDC panel recommends splitting childhood vaccines into multiple shots

    A US Centers for Disease Control vaccines advisory panel has voted to recommend separate vaccines for measles, mumps, rubella and chickenpox instead of a single combined jab. The advisory committee on immunisation practices (ACIP) shifted from recommending the combined MMRV vaccine to separate MMR and chickenpox doses. The move has raised concerns about compliance and [...]

  • Air pollution can affect sleep quality, study finds

    Air pollution is affecting how well people sleep, according to a global review of 1.2 million people across six countries. The metastudy analysed 25 high-quality studies since 2015, covering people over 45 years old in China, India, the US, Germany and other nations. Particle pollution, nitrogen dioxide and carbon dioxide were all linked to shorter [...]

  • Stronger communication and access to health info top safety priorities for UK patients, survey reveals

    Unclear, inconsistent or delayed communication is adversely impacting patient health, with 61 per cent of patients reporting that their mental health has been negatively affected, a new survey has revealed. The survey of 2,000 UK patients was commissioned by EHR and practice management platform, Semble. Poor communication – which is often out of clinicians’ hands [...]

  • Boston Scientific receives CE mark for expanded indication of INGEVITY™+ Pacing Leads

    Boston Scientific Corporation (NYSE: BSX) has received CE mark  approval to expand the indication for its current-generation INGEVITY™+ Pacing Leads – thin wires that are implanted in the heart and connected to a pacemaker. This expansion now includes conduction system pacing (CSP) and sensing of the left bundle branch area (LBBA) of the heart when [...]

  • Biostate AI launches AI agent that compresses research cycles from years to days

    Biostate AI, a company accelerating biological research through AI models, today announced the launch of K-Dense Beta, a comprehensive multi-agent AI research system that can compress research cycles from years to days, while eliminating hallucinations that plague generative AI models. In testing, K-Dense made a scientific breakthrough in longevity research, which will be published in [...]